Belete Mengistu, Kebede Deribe, Fikreab Kebede, Sarah Martindale, Mohammed Hassan, Heven Sime, Charles Mackenzie, Abate Mulugeta, Mossie Tamiru, Mesfin Sileshi, Asrat Hailu, Teshome Gebre, Amha Fentaye, Biruck Kebede


Lymphatic filariasis (LF) is one of the most debilitating and disfiguring diseases common in Ethiopia and is caused by Wuchereria bancrofti.  Mapping for LF has shown that 70 woredas (districts) are endemic and 5.9 million people are estimated to be at risk. The national government’s LF elimination programme commenced in 2009 in 5 districts integrated with the onchocerciasis programme. The programme developed gradually and has shown significant progress over the past 6 years, reaching 100% geographical coverage for mass drug administration (MDA) by 2016. To comply with the global LF elimination goals an integrated morbidity management and disability prevention (MMDP) guideline and a burden assessment programme has also been developed; MMDP protocols and a hydrocoele surgical handbook produced for country-wide use. In Ethiopia, almost all LF endemic districts are co-endemic with malaria and vector control aspects of the activities are conducted in the context of malaria programme as the vectors for both diseases are mosquitoes. In order to monitor the elimination, 11 sentinel and spot-check sites have been established and baseline information has been collected. Although significant achievements have been achieved in the scale up of the LF elimination programme, there is still a need to strengthen operational research to generate programme-relevant evidence, to increase access to morbidity management services, and to improve monitoring and evaluation of the LF programme. However, the current status of implementation of the LF national programme indicates that Ethiopia is poised to achieve the 2020 goal of elimination of LF. Nevertheless, to achieve this goal, high and sustained treatment coverage and strong monitoring and evaluation of the programme are essential.

Keywords: Lymphatic filariasis, Wuchereria bancrofti, Ethiopia


Full Text:



Ramaiah KD, Ottesen EA. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease. PLoS Negl Trop Dis. 2014;8(11):e3319.

WHA (World Health Assembly]. 50th World Health Assembly agenda item 20 on elimination of lymphatic filariasis as a public health problem. Geneva, Switzerland 13 May 1997. Resolution of the executive board of the WHO, 1997.

Addiss DG. Global Elimination of Lymphatic Filariasis: addressing the public health problem. PLoS Negl Trop Dis. 2010;4(6):e741.

WHO. Global programme to Eliminate Lymphatic Filariasis: progress report, 2014. Geneva, World Health Organization Weekly Epidemiological Record. 2015;90:489-504.

Deribe K, Meribo K, Gebre T, et al. The burden of Neglected Tropical Diseases in Ethiopia, and opportunities for integrated control and elimination. Parasit Vectors. 2012;5(1):240.

Rebollo MP, Sime H, Assefa A, Cano J, Deribe K, Gonzalez-Escalada A, et al. Shrinking the Lymphatic Filariasis Map of Ethiopia: Reassessing the Population at Risk through Nationwide Mapping. PLoS Negl Trop Dis. 2015;9(11):e0004172.

Shiferaw W, Kebede T, Graves PM, Golasa L, Gebre T, Mosher AW, et al. Lymphatic Filariasis in western Ethiopia with special emphasis on prevalence of Wuchereria Bancrofti antigenaemia in and around Onchocerciasis endemic areas. Trans R Soc Trop Med Hyg 2012;106(2):117-27.

Federal Democratic Republic of Ethiopia Ministry of Health. Second Edition of National Neglected Tropical Diseases Master Plan 2015/16 - 2019/20 (2008-2012 EFY). Addis Ababa, Ethiopia. 2016.

Federal Democratic Republic of Ethiopia Ministry of Health. Guidelines for vector control. Addis Ababa, Ethiopia. 2010.

Federal Democratic Republic of Ethiopia Ministry of Health. National Malaria Strategic Plan: 2014-2020. Addis Ababa, Ethiopia. 2014.

WHO. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic Filariasis: a manual for national elimination programmes. Geneva, Switzerland. 2011.


  • There are currently no refbacks.

Comments on this article

View all comments

Kirkos Sub-City, Woreda 05
Roosevelt street, Infront of Africa Union main gate
Tel: +251 115 547982 Fax: +251 115 151005
P.O.Box 2179 Email:
Copyright © Ethiopian Medical Association 2014 All rights Reserved

Powered by OJS & Designed and Hosted by MAKE Enterprise